The association between altered intestinal microbiome, impaired systemic and ocular surface immunity, and impaired wound healing response after corneal alkaline-chemical injury in diabetic mice

Purpose We aim to investigate the effect of sustained hyperglycemia on corneal epithelial wound healing, ocular surface and systemic immune response, and microbiome indices in diabetic mice compared to controls after alkaline chemical injury of the eye. Methods Corneal alkaline injury was induced in the right eye of Ins2Akita (Akita) mice and wild-type mice. The groups were observed at baseline and subsequently days 0, 3, and 7 after injury. Corneal re-epithelialization was observed under slit lamp with fluorescein staining using a cobalt blue light filter. Enucleated cornea specimens were compared at baseline and after injury for changes in cornea thickness under hematoxylin and eosin staining. Tear cytokine and growth factor levels were measured using protein microarray assay and compared between groups and time points. Flow cytometry was conducted on peripheral blood and ocular surface samples to determine CD3+CD4+ cell count. Fecal samples were collected, and gut microbiota composition and diversity pattern were measured using shotgun sequencing. Results Akita mice had significantly delayed corneal wound healing compared to controls. This was associated with a reduction in tear levels of vascular endothelial growth factor A, angiopoietin 2, and insulin growth factor 1 on days 0, 3, and 7 after injury. Furthermore, there was a distinct lack of upregulation of peripheral blood and ocular surface CD3+CD4+ cell counts in response to injury in Akita mice compared to controls. This was associated with a reduction in intestinal microbiome diversity indices in Akita mice compared to controls after injury. Specifically, there was a lower abundance of Firmicutes bacterium M10-2 in Akita mice compared to controls after injury. Conclusion In diabetic mice, impaired cornea wound healing was associated with an inability to mount systemic and local immune response to ocular chemical injury. Baseline and post-injury differences in intestinal microbial diversity and abundance patterns between diabetic mice and controls may potentially play a role in this altered response.

[1]  K. Shih,et al.  Lycium barbarum polysaccharide promotes corneal Re-epithelialization after alkaline injury. , 2022, Experimental eye research.

[2]  Nicholas R. Waters,et al.  A compilation of fecal microbiome shotgun metagenomics from hematopoietic cell transplantation patients , 2022, Scientific data.

[3]  J. Pannek,et al.  Systematic review of the changes in the microbiome following spinal cord injury: animal and human evidence , 2022, Spinal Cord.

[4]  S. Friess,et al.  Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis , 2021, Acta neuropathologica communications.

[5]  P. Cravedi,et al.  T Cells and Acute Kidney Injury: A Two-Way Relationship , 2020, Frontiers in Immunology.

[6]  T. C. Ng,et al.  Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2Akita/+ mice , 2020, BMJ open diabetes research & care.

[7]  M. Rosenblum,et al.  Regulatory T cells in skin injury: At the crossroads of tolerance and tissue repair , 2020, Science Immunology.

[8]  J. Kiecolt-Glaser,et al.  Stress, depression, diet, and the gut microbiota: human–bacteria interactions at the core of psychoneuroimmunology and nutrition , 2019, Current Opinion in Behavioral Sciences.

[9]  N. Kounis,et al.  Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations , 2019, Journal of Cell Communication and Signaling.

[10]  P. Tripathi,et al.  Gut microbiome and type 2 diabetes: where we are and where to go? , 2019, The Journal of nutritional biochemistry.

[11]  A. Shimizu,et al.  PPARα Agonist Suppresses Inflammation after Corneal Alkali Burn by Suppressing Proinflammatory Cytokines, MCP-1, and Nuclear Translocation of NF-κB , 2018, Molecules.

[12]  L. Tong,et al.  Tear Proteins Calcium binding protein A4 (S100A4) and Prolactin Induced Protein (PIP) are Potential Biomarkers for Thyroid Eye Disease , 2018, Scientific Reports.

[13]  Yulong Yin,et al.  Gut Microbiota and Type 1 Diabetes , 2018, International journal of molecular sciences.

[14]  Linhua Zhao,et al.  Intestinal Immunomodulatory Cells (T Lymphocytes): A Bridge between Gut Microbiota and Diabetes , 2018, Mediators of inflammation.

[15]  G. Mithieux.  Does Akkermansia muciniphila play a role in type 1 diabetes? , 2018, Gut.

[16]  F. Bier,et al.  Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation , 2017, Scientific Reports.

[17]  H. Lee,et al.  Clinical Effect of IRT-5 Probiotics on Immune Modulation of Autoimmunity or Alloimmunity in the Eye , 2017, Nutrients.

[18]  Lanjuan Li,et al.  Protective Effect of Akkermansia muciniphila against Immune-Mediated Liver Injury in a Mouse Model , 2017, Front. Microbiol..

[19]  A. Laude,et al.  The effect of intravitreal injections on dry eye, and proposed management strategies , 2017, Clinical ophthalmology.

[20]  A. Ljubimov.  Diabetic complications in the cornea , 2017, Vision Research.

[21]  K. Lam,et al.  A systematic review on the impact of diabetes mellitus on the ocular surface , 2017, Nutrition & Diabetes.

[22]  Ji Liu,et al.  Human Microbiota and Ophthalmic Disease , 2016, The Yale journal of biology and medicine.

[23]  Ting Wu,et al.  MK2 inhibitor reduces alkali burn-induced inflammation in rat cornea , 2016, Scientific Reports.

[24]  R. Xavier,et al.  Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease , 2016, Science.

[25]  V. Vieira-Potter,et al.  Ocular Complications of Diabetes and Therapeutic Approaches , 2016, BioMed research international.

[26]  W. D. de Vos,et al.  Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. , 2015, Carcinogenesis.

[27]  M. Shukry,et al.  Aloe vera gel facilitates re-epithelialization of corneal alkali burn in normal and diabetic rats , 2015, Clinical ophthalmology.

[28]  J. Segre.  Microbial growth dynamics and human disease , 2015, Science.

[29]  E. Murphy,et al.  Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk , 2015, Current opinion in clinical nutrition and metabolic care.

[30]  Liza Konnikova,et al.  Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells , 2015, Science.

[31]  Lixin Xie,et al.  Substance P Promotes Diabetic Corneal Epithelial Wound Healing Through Molecular Mechanisms Mediated via the Neurokinin-1 Receptor , 2014, Diabetes.

[32]  Chunxiang Zhang,et al.  Pro-Inflammatory Chemokine CCL2 (MCP-1) Promotes Healing in Diabetic Wounds by Restoring the Macrophage Response , 2014, PloS one.

[33]  C. Klemke,et al.  Peripheral blood sCD3− CD4+ T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma , 2014, Hematological oncology.

[34]  Eduardo Achar,et al.  Use of insulin-like growth factor in the healing of open wounds in diabetic and non-diabetic rats. , 2014, Acta cirurgica brasileira.

[35]  K. Yi,et al.  Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation. , 2013, Investigative ophthalmology & visual science.

[36]  Y. Sanz,et al.  Understanding the role of gut microbes and probiotics in obesity: how far are we? , 2013, Pharmacological research.

[37]  P. Chambon,et al.  Insulin-like growth factor-1 promotes wound healing in estrogen-deprived mice: new insights into cutaneous IGF-1R/ERα cross talk. , 2012, The Journal of investigative dermatology.

[38]  T. Jørgensen,et al.  The association between insulin-like-growth-factor I and insulin resistance: a general population study in danish adults , 2012 .

[39]  Nele Friedrich,et al.  The Association Between IGF-I and Insulin Resistance , 2012, Diabetes Care.

[40]  F. X. Yu,et al.  Impaired epithelial wound healing and EGFR signaling pathways in the corneas of diabetic rats. , 2011, Investigative ophthalmology & visual science.

[41]  P. McGuire,et al.  A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. , 2011, Investigative ophthalmology & visual science.

[42]  S. Sørensen,et al.  Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.

[43]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[44]  G. Casella,et al.  Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model , 2009, The ISME Journal.

[45]  T. Wong,et al.  Vascular endothelial growth factor and diabetic complications , 2008, Progress in Retinal and Eye Research.

[46]  Masahiro Yamamoto,et al.  ATP drives lamina propria TH17 cell differentiation , 2008, Nature.

[47]  M. Bartoli,et al.  Vascular endothelial growth factor in eye disease , 2008, Progress in Retinal and Eye Research.

[48]  G. Tesch.  MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. , 2008, American journal of physiology. Renal physiology.

[49]  E. Feskens,et al.  The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH. , 2007, European journal of endocrinology.

[50]  S. Melmed.  Medical progress: Acromegaly. , 2006, The New England journal of medicine.

[51]  T. Gardner,et al.  The Ins2Akita mouse as a model of early retinal complications in diabetes. , 2005, Investigative ophthalmology & visual science.

[52]  G. Lip,et al.  Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. , 2005, Atherosclerosis.

[53]  L. Aiello,et al.  Role of vascular endothelial growth factor in diabetic vascular complications. , 2000, Kidney international. Supplement.

[54]  A. Barkan.  Acromegaly , 1890, Trends in Endocrinology & Metabolism.

[55]  R. O. Schultz,et al.  Diabetic keratopathy. , 1981, Transactions of the American Ophthalmological Society.